SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

Navidea Biopharmaceutical Q1 EPS $(0.11) Misses $(0.08) Estimate

Navidea Biopharmaceutical (AMEX:NAVB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.08) by 37.5 percent. This is a 15.38 percent increase over losses of $(0.13) per

05/11/2021 16:03
Navidea Biopharmaceutical (AMEX:NAVB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.08) by 37.5 percent. This is a 15.38 percent increase over losses of $(0.13) per share from the same period last year.